Evidence generation plan for artificial intelligence (AI) technologies to aid opportunistic detection of vertebral fragility fractures: early value assessment
5 Minimum evidence standards
The evidence considered by NICE primarily focuses on diagnostic accuracy, failure rates, training and implementation of the artificial intelligence (AI) technologies in varied non-NHS settings. All the technologies that have been recommended for use in the NHS during the evidence generation period have some implementation experience in the NHS. The companies did not report any safety concerns. The technologies demonstrated potential to be cost effective for opportunistic detection of vertebral fragility fractures. But, more information is still needed to fully understand the benefits they may provide. More evidence is needed on:
-
the AI technologies' impacts on health-related quality of life
-
the diagnostic accuracy and failure rates of the AI technologies compared with NHS standard care
-
longer-term clinical and resource-use impacts of AI technologies to the NHS
-
the impact on the care pathway.
This evidence is essential to future NICE decision making. It will also potentially inform the optimum use and implementation of AI technologies for vertebral fragility fracture detection in the NHS.
This page was last updated: